Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar

Описание к видео Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar

Dr. Julian Segan discusses Abstract 1425 at ACR22 Convergence.

Abstract 1425: Treatment Persistence and Switching Patterns of ABP 501 (AMGEVITA®) in German Patients with Rheumatic Diseases

Комментарии

Информация по комментариям в разработке